| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/07/2001 | US6270763 Recombinant products are useful for diagnosis of allergy and for therapeutic treatment of allergy. |
| 08/07/2001 | US6270758 Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects |
| 08/07/2001 | US6270747 Inhibiting hypersecretion of mucus in lungs and airways by the administration of an egf-r antagonist. |
| 08/07/2001 | US6270746 Assay for the identification of IgE antibody suppressors |
| 08/07/2001 | CA2211006C Topically applied pharmaceutical composition, method of preparing it and its use |
| 08/07/2001 | CA2145242C Oral pharmaceutical preparation |
| 08/07/2001 | CA2139217C Vaccine composition for eliciting an immune response against n-glycolylated gangliosides and its use for cancer treatment |
| 08/07/2001 | CA2121199C Ether derivatives |
| 08/07/2001 | CA1341281C Immunotherapy of tumor with monoclonal antibody against the 17-1a antigen |
| 08/02/2001 | WO2001055392A2 Nuclear hormone receptors |
| 08/02/2001 | WO2001055370A2 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
| 08/02/2001 | WO2001055358A2 Phosphodiesterases |
| 08/02/2001 | WO2001055357A2 Myeloid colony stimulating factor and uses thereof |
| 08/02/2001 | WO2001055356A2 Human protein kinases and protein kinase-like enzymes |
| 08/02/2001 | WO2001055341A2 Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen |
| 08/02/2001 | WO2001055337A2 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 08/02/2001 | WO2001055336A2 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 08/02/2001 | WO2001055333A2 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
| 08/02/2001 | WO2001055219A2 scsCNTFR/NNT-1 FUSION PROTEIN |
| 08/02/2001 | WO2001055215A1 Therapeutic peptides |
| 08/02/2001 | WO2001055199A1 Peptide fragments of colostrinin and their use |
| 08/02/2001 | WO2001055188A1 A new polypeptide-human zinc finger protein 46 and the polynucleotide encoding it |
| 08/02/2001 | WO2001055187A1 A new polypeptide-zinc finger protein 49 and the polynucleotide encoding it |
| 08/02/2001 | WO2001055186A1 A new polypeptide-human zinc finger protein 14 and the polynucleotide encoding it |
| 08/02/2001 | WO2001055185A1 A new polypeptide-ribosome protein l20,16 and the polynucleotide encoding it |
| 08/02/2001 | WO2001055184A1 A new polypeptide-human zinc finger protein 19 and the polynucleotide encoding it |
| 08/02/2001 | WO2001055152A1 BENZOXATHIEPINO[3,4-b]PYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS |
| 08/02/2001 | WO2001055149A1 Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl acetic acid |
| 08/02/2001 | WO2001055134A2 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vassopressin receptors |
| 08/02/2001 | WO2001055130A2 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors |
| 08/02/2001 | WO2001055128A1 Formulation for protection against oxidative stress containing benzofuranone derivatives |
| 08/02/2001 | WO2001055121A1 Azepine derivatives |
| 08/02/2001 | WO2001055119A2 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 08/02/2001 | WO2001055115A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/02/2001 | WO2001055112A1 Method for preparing alpha-sulfonyl hydroxamic acid derivatives |
| 08/02/2001 | WO2001055106A2 Novel melanocortin receptor agonists and antagonists |
| 08/02/2001 | WO2001054732A1 Antibodies against ctla4 (cd152), conjugates comprising same, and uses thereof |
| 08/02/2001 | WO2001054723A1 Therapeutic method for reducing angiogenesis |
| 08/02/2001 | WO2001054722A1 Pre-transplant accommodated organs resistant to anti-donor immunity |
| 08/02/2001 | WO2001054721A1 Antagonist of th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseases |
| 08/02/2001 | WO2001054720A1 Pharmaceutical composition for immunomodulation and preparation of vaccines comprising an antigen and an immunogenic oligodeoxynucleotide and a polycationic polymer as adjuvants |
| 08/02/2001 | WO2001054717A1 Vaccine composition, process and methods |
| 08/02/2001 | WO2001054716A2 Genetically engineered tumor cell vaccines |
| 08/02/2001 | WO2001054707A2 Modification of surface proteins by aminopeptidase inhibitors |
| 08/02/2001 | WO2001054690A1 Pharmaceutical compositions containing anti-beta 1 integrin compounds and uses |
| 08/02/2001 | WO2001054687A1 Ophthalmic anti-allergy compositions suitable for use with contact lenses |
| 08/02/2001 | WO2001054672A2 Closure of bacterial ghosts |
| 08/02/2001 | WO2001054667A1 Electrospun pharmaceutical compositions |
| 08/02/2001 | WO2001014548A3 New g-protein coupled receptor and dna sequences thereof |
| 08/02/2001 | WO2001012189A8 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 08/02/2001 | WO2001004305A3 Human proteins involved in detoxification |
| 08/02/2001 | WO2001004155A3 Feline interleukin-12 as an immune stimulant |
| 08/02/2001 | WO2001000828A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/02/2001 | WO2000069898A3 Molecular interactions in allergy cells |
| 08/02/2001 | WO2000067801A3 Prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 08/02/2001 | WO2000047625A3 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
| 08/02/2001 | WO2000047603A3 16-hydroxyestratrienes as selective estrogens |
| 08/02/2001 | WO2000046391A9 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
| 08/02/2001 | US20010011124 Genetic engineering |
| 08/02/2001 | US20010011093 Arylgycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 08/02/2001 | US20010011092 High affinity ligands for nociceptin receptor ORL-1 |
| 08/02/2001 | US20010011077 Secreted cysteine rich protein-6 (SCRP-6); polynucleotides and processes for producing polypeptides |
| 08/02/2001 | US20010011072 Skin disorders; kidney and liver disorders |
| 08/02/2001 | US20010010934 Polypeptides that regulate epithelial specific gene expression; hypoproliferative disorders; medical diagnosis |
| 08/02/2001 | US20010010924 Inflammation, arthritis, septicemia, brain injury, autoimmune (inflammatory bowel, psoriasis)/bone/acute respiratory diseases, restenosis, AIDS, cancer (lympho-proliferative disorders, atheroscleosis, and Alzheimer's |
| 08/02/2001 | US20010010920 Complex of rapamycin-42 ester with dicarboxylic acid and fluorescein; antibody detection/generation; immunoglobulins; hybridomas; ring opening; precipitation |
| 08/02/2001 | US20010010913 Isolated polypeptide |
| 08/02/2001 | US20010010819 Septicemia |
| 08/02/2001 | US20010010818 Methods and formulations for reducing circulating antibodies |
| 08/02/2001 | EP1144431A3 16-hydroxyestratrienes as selective estrogens |
| 08/02/2001 | DE10004157A1 New pyridyl- or pyrimidinyl-substituted bicyclic pyrrole derivatives, are cyclokine release inhibitors useful for treating immune system-related disorders, e.g. cancer, multiple sclerosis or arthritis |
| 08/02/2001 | DE10003241A1 Verschließen von Bakterienghosts Closing bacterial ghosts |
| 08/02/2001 | DE10001372A1 Anti-CD3-Einzelketten-Antikörper mit humanem Cmu3- und Cmu4- Domänen Anti-CD3 single-chain antibody with human Cmu3- and Cmu4- domains |
| 08/02/2001 | CA2423122A1 Closure of bacterial ghosts |
| 08/02/2001 | CA2401086A1 Antagonist of th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseases |
| 08/02/2001 | CA2398756A1 Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen |
| 08/02/2001 | CA2398728A1 Novel melanocortin receptor agonists and antagonists |
| 08/02/2001 | CA2398615A1 Benzoxathiepino[3,4-b]pyridine derivatives, process for their preparation and their use as medicaments |
| 08/02/2001 | CA2398564A1 Nuclear hormone receptors |
| 08/02/2001 | CA2398561A1 Method for preparing alpha-sulfonyl hydroxamic acid derivatives |
| 08/02/2001 | CA2398548A1 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 08/02/2001 | CA2398546A1 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 08/02/2001 | CA2398503A1 Therapeutic method for reducing angiogenesis |
| 08/02/2001 | CA2398430A1 Human protein kinases and protein kinase-like enzymes |
| 08/02/2001 | CA2398396A1 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
| 08/02/2001 | CA2398283A1 Peptide fragments of colostrinin and their use |
| 08/02/2001 | CA2398003A1 Phosphodiesterases |
| 08/02/2001 | CA2397493A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/02/2001 | CA2397267A1 Peptide fragments and uses thereof as type-1 interferon antagonist |
| 08/02/2001 | CA2396884A1 Pharmaceutical composition for immunomodulation and preparation of vaccines comprising an antigen and an immunogenic oligodeoxynucleotide and a polycationic polymer as adjuvants |
| 08/02/2001 | CA2396640A1 Electrospun pharmaceutical compositions |
| 08/02/2001 | CA2297706A1 Anticonvulsive and antiallergic/anti-asthmatic pyrazolo-(3,4-d)pyrimidines having affinity for the adenosine receptor, and process for their preparation |
| 08/01/2001 | EP1120464A2 Stabilizing peptides, polypeptides and antibodies which include them |
| 08/01/2001 | EP1120417A2 Xanthine derivatives for the treatment of cerebrovascular disorders |
| 08/01/2001 | EP1119629A2 Oxidoreductase molecules |
| 08/01/2001 | EP1119623A1 Mage-a3 peptides presented by hla class ii molecules |
| 08/01/2001 | EP1119620A2 Polynucleotides coding for secreted polypeptides. some having similarity to syncollin or claudin or cytokine. their therapeutic uses |
| 08/01/2001 | EP1119573A2 Bipyridine manganese complexes |
| 08/01/2001 | EP1119568A1 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 08/01/2001 | EP1119567A1 Quinazoline derivatives |